Share:
  • Title:MonarchE 4-year: abemaciclib + endocrine therapy for HR+, HER2-, node-positive, high-risk early BC
  • Duration: 4:03
  • Plays: 3.5K views
  • Published: 1 year ago
Download MP3
Download MP4


Simillar Videos

Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC▶️ 2:52
Updated Overall Efficacy And Safety Of Selpercatinib In Patients With Ret Fusion+ Nsclc 3.5K views • 3 years ago
VJOncology at BTOG 2023▶️ 0:34
Vjoncology At Btog 2023 3.5K views • 1 year ago
Combining radiotherapy with novel agents in NSCLC▶️ 0:47
Combining Radiotherapy With Novel Agents In Nsclc 3.5K views • 2 years ago
Second-line treatment of mHSPC▶️ 0:38
Second-line Treatment Of Mhspc 3.5K views • 4 years ago
Updated analysis of DESTINY-Gastric02: T-DXd in HER2+ GEJ cancer who progressed with trastuzumab▶️ 2:58
Updated Analysis Of Destiny-gastric02: T-dxd In Her2+ Gej Cancer Who Progressed With Trastuzumab 3.5K views • 2 years ago